Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The levonorgestrel intrauterine device].

M Thiery1, H Van der Pas, W Delbarge

  • 1Universitäts-Frauenklinik, Gent, Belgien.

Geburtshilfe Und Frauenheilkunde
|February 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mortality and early neonatal morbidity in vaginal and abdominal deliveries in breech presentation.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2003
Same author

Development of a miniature, low-dose, frameless intrauterine levonorgestrel-releasing system for contraception and treatment: a review of initial clinical experience.

Reproductive biomedicine online·2002
Same author

Return to fertility in nulliparous and parous women after removal of the GyneFix intrauterine contraceptive system.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2002
Same author

[The intrauterine contraceptive implant without armature].

Gynecologie, obstetrique & fertilite·2001
Same author

Intrauterine contraception in the year 2001: can intrauterine device use be revived with new improved contraceptive technology?

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2001
Same author

Performance of the frameless IUD (Flexigard prototype inserter) and the TCu380A after six years as part of a WHO multicenter randomized comparative clinical trial in parous women.

Advances in contraception : the official journal of the Society for the Advancement of Contraception·2000
Same journal

Consensus on the Management of Inavolisib Side Effects. A Survey on Defined Side Effects, the Assumed Pathomechanism, Preventative and/or Therapeutic Measures Including the Integration of Additional Health Care Professionals - a Consensus Paper.

Geburtshilfe und Frauenheilkunde·2026
Same journal

Statement by the Uterus Commission of the Arbeitsgemeinschaft Gynäkologische Onkologie [German Gynecological Oncology Group] (AGO) on the ESGO-ESTRO-ESP Guideline 2025.

Geburtshilfe und Frauenheilkunde·2026
Same journal

Feasibility of <i>PIK3CA</i> Mutation Detection via Microfluidic Isolation of Disseminated Tumor Cells from Bone Marrow in Breast Cancer Patients.

Geburtshilfe und Frauenheilkunde·2026
Same journal

Stereotactic Vacuum-Assisted Biopsy in Photon-Counting Dedicated Spiral Breast CT: A Proof of Concept.

Geburtshilfe und Frauenheilkunde·2026
Same journal

RSV Prophylaxis in Neonates: Implementation and Parental Acceptance during the First RSV Season in Germany.

Geburtshilfe und Frauenheilkunde·2026
Same journal

Genital Herpes Simplex Virus (HSV) Infection During Pregnancy - Recommendations of the Working Group on Obstetrics and Prenatal Medicine (AGG - Section on Maternal Disorders).

Geburtshilfe und Frauenheilkunde·2026
See all related articles

The levonorgestrel IUD can reduce heavy periods for many women. However, it may cause no periods or spotting, so discuss potential bleeding changes before insertion.

Area of Science:

  • Reproductive Medicine
  • Contraception
  • Gynecology

Context:

  • Menorrhagia (heavy menstrual bleeding) is a common gynecological issue.
  • Conventional intrauterine devices (IUDs) can sometimes exacerbate menorrhagia.
  • Hormonal IUDs, like the levonorgestrel IUD, offer an alternative treatment approach.

Purpose:

  • To evaluate the efficacy of the levonorgestrel IUD in managing menorrhagia.
  • To characterize the bleeding patterns associated with the levonorgestrel IUD, including amenorrhea and spotting.
  • To inform clinical practice regarding patient counseling prior to levonorgestrel IUD insertion.

Summary:

  • The levonorgestrel IUD is effective in treating menorrhagia in women experiencing heavy menstrual bleeding with conventional IUDs.

Related Experiment Videos

  • A significant proportion of users experience altered bleeding patterns, specifically amenorrhea (absence of menstruation) and intermenstrual spotting.
  • These changes necessitate pre-insertion counseling to manage patient expectations regarding the novel bleeding profile induced by the steroid IUD.

    • Impact:

    • Provides a valuable therapeutic option for women suffering from IUD-related menorrhagia.
    • Highlights the importance of patient education and expectation management for hormonal contraceptives.
    • Contributes to improved patient satisfaction and adherence with levonorgestrel IUD therapy by addressing potential bleeding pattern concerns proactively.